Research Report for the year 2016

Scientific publications

Journal Articles:
  • Binder H, Kurz T, Teschner S, Kreutz C, Geyer M, Donauer J, Kraemer-Guth A, Timmer J, Schumacher M, Walz G: Dealing with prognostic signature instability: a strategy illustrated for cardiovascular events in patients with end-stage renal disease. Bmc Med Genomics, 2016; 9 (online): 43. :
  • Bonofiglio F, Beyersmann J, Schumacher M, Koller M, Schwarzer G: Meta-analysis for aggregated survival data with competing risks: a parametric approach using cumulative incidence functions. Research Synthesis Methods, 2016; 7: 282-293. :
  • Cattaneo G, Schumacher M, Maurer C, Wolfertz J, Jost T, Büchert M, Keuler A, Boos L, Shah MJ, Foerster K, Niesen W-D, Ihorst G, Urbach H, Meckel S: Endovascular Cooling Catheter for Selective Brain Hypothermia: An Animal Feasibility Study of Cooling Performance. Am J Neuroradiol, 2016; 37: 885-891. :
  • Doerken S, Mockenhaupt M, Naldi L, Schumacher M, Sekula P: The case-crossover design via penalized regression. Bmc Med Res Methodol, 2016; 16 (online): 103. :
  • Engelhardt M, Dold SM, Ihorst G, Zober A, Möller M, Reinhardt H, Hieke S, Schumacher M, Wäsch: Geriatric assessment in multiple myeloma patients: validation of the International Myeloma Working Group (IMWG) score and comparison with other common comorbidity scores. Haematologica, 2016; 101: 1110-1119. :
  • Hieke S, Benner A, Schlenk RF, Schumacher M, Bullinger L, Binder H: Identifying Prognostic SNPs in Clinical Cohorts: Complementing Univariate Analyses by Resampling and Multivariable Modeling. Plos One, 2016; 11 (online): e0155226. :
  • Hieke S, Benner A, Schlenl RF, Schumacher M, Bullinger L, Binder H: Integrating multiple molecular sources into a clinical risk prediction signature by extracting complementary information: Bmc Bioinformatics, 2016; 17 (online): 327. :
  • Proctor T, Schumacher M: Analysing adverse events by time-to-event models: the CLEOPATRA study. Pharm Stat, 2016; 15: 306-314. :
  • Schumacher M: Entwicklung klinischer Studien von Paul Martini bis heute Drug Research, 2016; 66: S5-S7. :
  • Steinhauser S, Schumacher M, Rücker G: Modelling multiple thresholds in meta-analysis of diagnostic test accuracy studies. Bmc Medical Research Methodology, 2016; 16 (online): 97. :
  • Stewardson AJ, Allignol A, Beyersmann J, Graves N, Schumacher M, Meyer R, Tacconelli E, De Angelis G, Farina C, Pezzoli F, Bertrand X, Gbaguidi-Haore H, Edgeworth J, Tosas O, Martinez JA, Ayala-Blanco MP, Pan A, Zoncada A, Marwick CA, Nathwani D, Seifert H, Hos N, Hagel S, Pletz M, Harbarth S, the TIMBER Study Group 18: The health and economic burden of bloodstream infections caused by antimicrobial-susceptible and non-susceptible Enterobacteriaceae and Staphylococcus aureus in European hospitals, 2010 and 2011: a multicentre retrospective cohort study. Eurosurveillance, 2016; 21 (online): 30319. :
  • Winzer K-J, Buchholz A, Schumacher M, Sauerbrei W: Improving the Prognostic Ability through Better Use of Standard Clinical Data - The Nottingham Prognostic Index as an Example. Plos One, 2016; 11 (online): e0149977. :
  • Wolkewitz M, Cooper B, Palomar-Martinez M, Alvarez-Lerma F, Olaechea-Astigarraga P Barnett AG, Schumacher M: Multiple time scales in modeling the incidence of infections acquired in intensive care units. Bmc Med Res Methodol, 2016; 16 (online): 116. :
  • Wolkewitz M, Palomar-Martinez M, Olaechea-Astigarraga P, Alvarez-Lerma F, Schumacher M: A full competing risk analysis of hospital-acquired infections can easily be performed by a case-cohort approach: J Clin Epidemiol, 2016; 74: 187-193. :
  • Wolkewitz M, Schumacher M: Neuraminidase Inhibitors and Hospital Mortality in British Patients with H1N1 Influenza A: A Re-Analysis of Observational Data. Plos One, 2016; 11 (online): e0160430. :
Short Communications:
  • Binder N, Schumacher M: Incidence of Dementia over Three Decades in the Framingham Heart Study. New Engl J Med, 2016; 375: 92-93. :
  • Schmoor C, Bender R, Beyersmann J, Kieser M, Schumacher M: Adverse event development in clinical oncology trials. Lancet Oncol, 2016; 17 (online): e263-e264.
  • Schumacher M, Beyersmann J, Binder N: Contribution to the discussion on the paper by Keiding and Louis. Perils and potentials of self-selected entry to epidemiological studies and surveys (pp 319-376). J R Stat Soc A Stat, 2016; 179: 364-365. :
  • Schumacher M, Ohneberg K, Beyersmann J: Competing risk bias in prominent medical journals. J Clin Epidemiol, 2016; 80: 134-136. :
  • Schumacher M, Wanner C, Beyersmann J: Soluble Urokinase Receptor and Chronic Kidney Disease. New Engl J Med, 2016; 374: 890. :
  • Wolkewitz M, Beyersmann J, OhneberG K, Schumacher M: Re: "Comparison of statistical approaches for dealing with immortal time bias in drug effectnivenss studies. Am J Epidemiol, 2016; 184: 856-858. :